Abstract: The present invention relates to a big data evaluation method and system. The method comprises steps of: determining evaluated data, reference data and different statistical indexes for data evaluation according to a preset experimental requirement; performing comparative calculation according to the evaluated data, the reference data and the statistical indexes to obtain corresponding numerical values of the statistical indexes; normalizing the numerical values of the statistical indexes to obtain normalized data; establishing a multi-dimensional spatial coordinate system according to the normalized data, and determining a distance value between the preset evaluation data and the reference data according to the multi-dimensional spatial coordinate system; and judging the comprehensive simulation capability of the evaluated data according to the distance value.

Abstract: A movement adjustment system based on heart rates and rating of perceived exertion (RPE) feedbacks of different users is provided, including: a user client, a heart rate monitoring device, a server, and a doctor client. The user client includes an RPE self-rating module, an RPE data acquisition module, a user-side video movement display module, and a user-side data storage module. The heart rate monitoring device includes an exercise data acquisition module. The server includes a data input module, a core processor, and a video movement library. The doctor client includes a doctor-side video movement display module, a video movement sending module, and a doctor-side data storage module. The above system according to the present disclosure adjusts, based on objective heart rate feedbacks during exercise and subjective RPE feedbacks after the exercise of different users, movements of next exercise of a patient.

Abstract: A movement adjustment system based on heart rates and rating of perceived exertion (RPE) feedbacks of different users is provided, including: a user client, a heart rate monitoring device, a server, and a doctor client. The user client includes an RPE self-rating module, an RPE data acquisition module, a user-side video movement display module, and a user-side data storage module. The heart rate monitoring device includes an exercise data acquisition module. The server includes a data input module, a core processor, and a video movement library. The doctor client includes a doctor-side video movement display module, a video movement sending module, and a doctor-side data storage module. The above system according to the present disclosure adjusts, based on objective heart rate feedbacks during exercise and subjective RPE feedbacks after the exercise of different users, movements of next exercise of a patient.

Abstract: The invention relates to stable formulations of antibodies against human programmed death receptor PD-1, or antigen binding fragments thereof and a PH20 variant or fragment thereof. The invention further provides methods for treating various cancers with formulations of the invention. In some embodiments of the methods of the invention, the formulations are administered to a subject by subcutaneous administration.

Abstract: The present disclosure relates to a photoinitiating composition suitable for UV-LED light irradiation comprising: a) a photoinitiating system suitable for LED light irradiation having a wavelength in the range of 340-420 nm; b) a dispersing medium; wherein the dispersing medium comprises an organic solvent which is miscible with water.

Abstract: The present disclosure relates to an apparatus for differentially calculating target heart rates of different users, including: a user client, including a health data acquisition module, a medication data acquisition module, and a user-side target heart rate display module; a heart rate detection device, worn on a user and including an exercise test data acquisition module; a server, including a data input module and a core processor; and a doctor client, including a data sending module and a doctor-side target heart rate display module.

Abstract: A process for converting naphtha to light olefins comprises contacting a naphtha stream with a zeolitic catalyst to produce a light paraffin stream at conditions which dehydrogenate the naphtha to olefins, interconvert the olefins to lighter olefins and hydrogenate the lighter olefins to produce a light paraffin stream comprising ethane and propane. The catalyst may comprise a zeolite and a metal.

Abstract: A process for converting naphtha to light olefins comprises contacting a naphtha stream with a zeolitic catalyst to produce a light paraffin stream. The light paraffin may be separated into an ethane stream and a propane stream. The ethane in the ethane stream may be converted into ethylene, and the propane in the propane in the propane stream may be converted into propylene. The light paraffin stream may also be separated into a heavy stream which may be recycled back to the contacting step.

Abstract: Disclosed herein are methods of detecting viruses and methods of making a diagnosis of viral infection, by using RNA and DNA probes. According to some embodiments of the present disclosure, the method is useful in detecting and diagnosing SARS-CoV-2 infection. Accordingly, also disclosed herein are a kit for detecting SARS-CoV-2.

Abstract: The present invention relates to a spectrally selective emitter and a design method thereof. The designed emitter has a one-dimensional layered structure, including a first layer, a second layer and a third layer arranged in sequence, wherein both the first and third layers are hafnium oxide layers, and the second layer is a hafnium oxide layer with multiple erbium oxide nanoparticles distributed. The designed emitter is a material-type emitter with spectrally selective emittance. Compared with the traditional structure-type emitter, the material-type emitter has high thermal stability and oxidation resistance, which can fundamentally solve the high-temperature degradation problem.

Abstract: A pyrido[1,2-a]pyrimidinone compound or a pharmaceutical composition thereof for treating peripheral T cell lymphoma, and a method for or use of a pyrido[1,2-a]pyrimidinone compound for treating peripheral T cell lymphoma.

Abstract: An image processing method is provided, the method includes: performing area division on an input image to obtain a plurality of sub-images; determining a part of the plurality of sub-images as an image to be output; stitching respective sub-images of the image to be output to obtain a stitched image; and transmitting the stitched image, wherein the stitched image is smaller than the input image. An image jointing method is provided, the method includes: receiving a stitched image obtained by the image processing method according to the present disclosure; extracting respective sub-images of an image to be output from the stitched image; and jointing the respective sub-images to obtain a display image, wherein the jointing the respective sub-images refers to obtaining the display image by an operation inverse to a stitching process of stitching the respective sub-images to obtain the stitched image.

Abstract: The present application relates to a coating composition and wood article manufactured therefrom, the coating composition comprising: (A) a film-forming resin composition comprising a reactive donor capable of providing two or more nucleophilic carbanions, and a reactive acceptor comprising two or more carbon-carbon double bonds; (B) a catalyst for catalyzing the Michael addition crosslinking reaction between the reactive donor and the reactive acceptor, wherein the reactive donor has an aromatic epoxy backbone, and wherein the reactive donor has an epoxy equivalent weight in the range of from 400 to 1100 g/mol, preferably in the range of from 470 to 1000 g/mol, more preferably in the range of from 470 to 900 g/mol.

Abstract: An array substrate is provided. The array substrate includes a base substrate and a plurality of gate lines, a plurality of data lines, a common electrode layer and a plurality of pixel units arranged in an array disposed on the base substrate. Each of the pixel units includes a plurality of sub-pixel units defined by gate lines and data lines disposed to intersect each other laterally and vertically. The common electrode layer includes a plurality of common electrode blocks that double as self-capacitance electrodes, each of the common electrode blocks is connected with at least one wire, and the wires are in the middle of sub-pixel units of a same column.

Abstract: The present invention provides an anti-ErbB2 antibody-drug conjugate, a composition comprising the conjugate, a method for preparing the conjugate, and use of the conjugate.

Abstract: An improved MFI zeolite having low aluminum occupation at intersection sites characterized by an ortho-xylene to para-xylene uptake ratio of 0.1 to about 0.55. Processes for converting hydrocarbon or oxygenate to a product comprising light olefins and/or aromatics using the improved MFI zeolite as catalyst are also disclosed. Para-xylene in the product may be greater than about 24% of the xylenes.

Abstract: The present disclosure belongs to the biopharmaceutical field, and discloses uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system, and particularly uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system with symptoms of cough and/or expectoration and/or asthma. As indicated by the test results of the present disclosure, Trezastilbenoside has significant efficacy of relieving cough, eliminating phlegm, relieving asthma and anti-inflammation, and has a potential therapeutic effect on respiratory system diseases, thus possessing broad prospects in clinical application.

Abstract: The present disclosure is directed to an aqueous dispersion of polymeric particles having core-shell structure, the preparation thereof and the coating formed therefrom. In the polymeric particles, at least one of the polymeric core and the polymeric shell is formed from a monomers mixture comprising isobornyl (meth)acrylate and wherein the isobornyl (meth)acrylate is present in the monomers mixture in an amount of 1 wt % to 40 wt %, relative to the weight of the corresponding monomers mixture for the polymeric core or the polymeric shell.

Abstract: Provided are a UV-curable non-isocyanate polyurea polymer and a UV-curable coating composition containing the same. The UV-curable non-isocyanate polyurea polymer has one or more ethylenically unsaturated functional groups and the ethylenically unsaturated functional groups are attached to nitrogen atoms present in a backbone urea segment via —C(=0)- linkage. The nonisocyanate polyurea polymer is prepared by: (i) providing an ethylenically unsaturated compound having one or more carboxylic acid functional groups; and (ii) reacting said ethylenically unsaturated compound having one or more carboxylic acid functional groups with a multi-carbodiimide polymer to form the non-isocyanate polyurea polymer.